K Askaner1, A Rydelius2, S Engelholm3, L Knutsson4, J Lätt5, K Abul-Kasim6, P C Sundgren7. 1. Centre for Medical Imaging and Physiology, SUS, Malmoe, Sweden. Electronic address: krister.askaner@med.lu.se. 2. Department of Neurology, Lund, Sweden. 3. Department of Oncology, Lund, Sweden. 4. Department of Medical Radiation Physics, Lund University, Lund, Sweden; Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, US. 5. Centre for Medical Imaging and Physiology, SUS, Lund, Sweden. 6. Centre for Medical Imaging and Physiology, SUS, Malmoe, Sweden. 7. Institution of Clinical Sciences, Lund University, Lund, Sweden; Department of Radiology, University of Michigan, Ann Arbor, US.
Abstract
BACKGROUND: Differentiation between glioblastoma and brain metastasis may be challenging in conventional contrast-enhanced MRI. PURPOSE: To investigate if perfusion-weighted MRI is able to differentiate glioblastoma from metastasis and, as a second aim was to see if it was possible in the latter group, to predict the primary site of neoplasm. MATERIAL AND METHODS: Hundred and fourteen patients with newly discovered tumor lesion (76 metastases and 38 glioblastomas) underwent conventional contrast-enhanced MRI including dynamic susceptibility contrast perfusion sequence. The calculated relative cerebral blood volumes were analyzed in the solid tumor area, peritumoral area, area adjacent to peritumoral area, and normal appearing white matter in contralateral semioval center. The Student t-test was used to detect statistically significant differences in relative cerebral blood volume between glioblastomas and metastases in the aforementioned areas. Furthermore, the metastasis group was divided in four sub groups (lung-, breast-, melanoma-, and gastrointestinal origin) and using one-way ANOVA test. P-values < 0.05 were considered significant. RESULTS: Relative cerebral blood volume (rCBV) in the peritumoral edema was significantly higher in glioblastomas than in metastases (mean 3.2 ± 1.4 and mean 0.9 ± 0.7), respectively, (P < 0.0001). No significant differences in the solid tumor area or the area adjacent to edema were found, (P = 0.28 and 0.21 respectively). There were no significant differences among metastases in the four groups. CONCLUSION: It is possible to differentiate glioblastomas from metastases by measuring the CBV in the peritumoral edema. It is not possible to differentiate between brain metastases from different primaries (lung-, breast-, melanoma or gastrointestinal) using CBV-measurements in the solid tumor area, peritumoral edema or area adjacent to edema.
BACKGROUND: Differentiation between glioblastoma and brain metastasis may be challenging in conventional contrast-enhanced MRI. PURPOSE: To investigate if perfusion-weighted MRI is able to differentiate glioblastoma from metastasis and, as a second aim was to see if it was possible in the latter group, to predict the primary site of neoplasm. MATERIAL AND METHODS: Hundred and fourteen patients with newly discovered tumor lesion (76 metastases and 38 glioblastomas) underwent conventional contrast-enhanced MRI including dynamic susceptibility contrast perfusion sequence. The calculated relative cerebral blood volumes were analyzed in the solid tumor area, peritumoral area, area adjacent to peritumoral area, and normal appearing white matter in contralateral semioval center. The Student t-test was used to detect statistically significant differences in relative cerebral blood volume between glioblastomas and metastases in the aforementioned areas. Furthermore, the metastasis group was divided in four sub groups (lung-, breast-, melanoma-, and gastrointestinal origin) and using one-way ANOVA test. P-values < 0.05 were considered significant. RESULTS: Relative cerebral blood volume (rCBV) in the peritumoral edema was significantly higher in glioblastomas than in metastases (mean 3.2 ± 1.4 and mean 0.9 ± 0.7), respectively, (P < 0.0001). No significant differences in the solid tumor area or the area adjacent to edema were found, (P = 0.28 and 0.21 respectively). There were no significant differences among metastases in the four groups. CONCLUSION: It is possible to differentiate glioblastomas from metastases by measuring the CBV in the peritumoral edema. It is not possible to differentiate between brain metastases from different primaries (lung-, breast-, melanoma or gastrointestinal) using CBV-measurements in the solid tumor area, peritumoral edema or area adjacent to edema.
Authors: Santiago Cepeda; Sergio García-García; Ignacio Arrese; Gabriel Fernández-Pérez; María Velasco-Casares; Manuel Fajardo-Puentes; Tomás Zamora; Rosario Sarabia Journal: Front Oncol Date: 2021-02-02 Impact factor: 6.244
Authors: Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra Journal: Cancers (Basel) Date: 2022-03-10 Impact factor: 6.639
Authors: Leon Jekel; Waverly R Brim; Marc von Reppert; Lawrence Staib; Gabriel Cassinelli Petersen; Sara Merkaj; Harry Subramanian; Tal Zeevi; Seyedmehdi Payabvash; Khaled Bousabarah; MingDe Lin; Jin Cui; Alexandria Brackett; Amit Mahajan; Antonio Omuro; Michele H Johnson; Veronica L Chiang; Ajay Malhotra; Björn Scheffler; Mariam S Aboian Journal: Cancers (Basel) Date: 2022-03-08 Impact factor: 6.639